There is evidence that methoxylated estrogens, especially the 2-pathway methoxylated estrogens (E1 and E2), are associated with decreased breast cancer risk; 2-MeOE2, produced from 2-OHE2, has been described to have anti-proliferative, antingiogenic, and pro-apoptotic activity in multiple types of cancer.
2-OH(E1+E2) / 2-MeO(E1+E2) / Menopause
2-OH(E1+E2) / 2-MeO(E1+E2) / Menopause
Every lab result you’ve ever had, charted and explained.
Healthmatters is a tracker for your lab results. Upload a report from any lab, any country — every marker charted and explained.
Start with my report →Beyond 2-OH(E1+E2) / 2-MeO(E1+E2) / Menopause — 10,000+ markers explained
One 2-OH(E1+E2) / 2-MeO(E1+E2) / Menopause result tells you where you are. Your history tells you where you’re heading. Upload your past lab reports and see this marker — and every marker on them —every marker charted against your own lab’s ranges.
Start with this report →
Clinical Sources & References
All our content is backed by peer-reviewed studies, academic research, and trusted medical sources. We’re committed to accuracy and transparency — see our editorial policy for details.
Article Review Log
Written by
Healthmatters Editorial Team